John Paulson Buys 514,549 Shares of Bausch Health Companies Inc. (TSE:BHC) Stock

Bausch Health Companies Inc. (TSE:BHC - Get Free Report) Director John Paulson acquired 514,549 shares of Bausch Health Companies stock in a transaction that occurred on Wednesday, June 11th. The stock was purchased at an average cost of C$7.13 per share, for a total transaction of C$3,666,881.99.

John Paulson also recently made the following trade(s):

• On Tuesday, June 10th, John Paulson acquired 754,134 shares of Bausch Health Companies stock. The stock was purchased at an average cost of C$6.87 per share, for a total transaction of C$5,179,392.31.

Bausch Health Companies Stock Performance

BHC traded down C$0.11 during trading on Monday, reaching C$8.01. 746,307 shares of the company's stock were exchanged, compared to its average volume of 356,868. The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58. The stock has a market capitalization of C$2.08 billion, a P/E ratio of -11.72, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. The company's fifty day simple moving average is C$6.74 and its 200-day simple moving average is C$9.08. Bausch Health Companies Inc. has a 1 year low of C$5.45 and a 1 year high of C$13.74.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.